Free Trial
NASDAQ:PHAR

Pharming Group (PHAR) Stock Price, News & Analysis

Pharming Group logo
$10.65 -0.06 (-0.56%)
Closing price 07/2/2025 03:59 PM Eastern
Extended Trading
$10.62 -0.04 (-0.33%)
As of 08:00 AM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

About Pharming Group Stock (NASDAQ:PHAR)

Key Stats

Today's Range
$10.52
$10.69
50-Day Range
$8.50
$12.16
52-Week Range
$6.65
$12.61
Volume
2,238 shs
Average Volume
6,097 shs
Market Capitalization
$724.52 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$30.00
Consensus Rating
Buy

Company Overview

Pharming Group Stock Analysis - MarketRank™

See Top-Rated MarketRank™ Stocks
56th Percentile Overall Score

PHAR MarketRank™: 

Pharming Group scored higher than 56% of companies evaluated by MarketBeat, and ranked 464th out of 940 stocks in the medical sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

  • Consensus Rating

    Pharming Group has received a consensus rating of Buy. The company's average rating score is 3.00, and is based on 3 buy ratings, no hold ratings, and no sell ratings.

  • Amount of Analyst Coverage

    Pharming Group has received no research coverage in the past 90 days.

  • Read more about Pharming Group's stock forecast and price target.
  • Earnings Growth

    Earnings for Pharming Group are expected to grow in the coming year, from ($0.20) to $0.03 per share.

  • Price to Earnings Ratio vs. the Market

    The P/E ratio of Pharming Group is -53.25, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

  • Price to Earnings Ratio vs. Sector

    The P/E ratio of Pharming Group is -53.25, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

  • Price to Book Value per Share Ratio

    Pharming Group has a P/B Ratio of 3.28. P/B Ratios above 3 indicate that a company could be overvalued with respect to its assets and liabilities.

  • Read more about Pharming Group's valuation and earnings.
  • Percentage of Shares Shorted

    0.00% of the float of Pharming Group has been sold short.
  • Short Interest Ratio / Days to Cover

    Pharming Group has a short interest ratio ("days to cover") of 0.4, which is generally considered an acceptable ratio of short interest to trading volume.
  • Change versus previous month

    Short interest in Pharming Group has recently decreased by 62.86%, indicating that investor sentiment is improving significantly.
  • Dividend Yield

    Pharming Group does not currently pay a dividend.

  • Dividend Growth

    Pharming Group does not have a long track record of dividend growth.

  • Percentage of Shares Shorted

    0.00% of the float of Pharming Group has been sold short.
  • Short Interest Ratio / Days to Cover

    Pharming Group has a short interest ratio ("days to cover") of 0.4, which is generally considered an acceptable ratio of short interest to trading volume.
  • Change versus previous month

    Short interest in Pharming Group has recently decreased by 62.86%, indicating that investor sentiment is improving significantly.
  • News Sentiment

    Pharming Group has a news sentiment score of 0.71. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a lower news sentiment than the 0.90 average news sentiment score of Medical companies.
  • News Coverage This Week

    MarketBeat has tracked 3 news articles for Pharming Group this week, compared to 3 articles on an average week.
  • Search Interest

    4 people have searched for PHAR on MarketBeat in the last 30 days.
  • Insider Buying vs. Insider Selling

    In the past three months, Pharming Group insiders have not sold or bought any company stock.

  • Percentage Held by Insiders

    Only 2.07% of the stock of Pharming Group is held by insiders.

  • Percentage Held by Institutions

    Only 0.03% of the stock of Pharming Group is held by institutions.

  • Read more about Pharming Group's insider trading history.
Receive PHAR Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Pharming Group and its competitors with MarketBeat's FREE daily newsletter.

PHAR Stock News Headlines

AS:PHAR Financials | Pharming Group NV - Investing.com
The Trump Dump is starting; Get out of stocks now?
The first 365 days of the Trump presidency… Will be the best time to get rich in American history.
European Penny Stocks Under €200M Market Cap To Watch
See More Headlines

PHAR Stock Analysis - Frequently Asked Questions

Pharming Group's stock was trading at $10.06 at the beginning of the year. Since then, PHAR shares have increased by 5.9% and is now trading at $10.65.
View the best growth stocks for 2025 here
.

Pharming Group N.V. Sponsored ADR (NASDAQ:PHAR) released its earnings results on Thursday, May, 8th. The company reported ($0.22) earnings per share for the quarter, beating analysts' consensus estimates of ($0.25) by $0.03. The firm had revenue of $79.09 million for the quarter, compared to the consensus estimate of $67.74 million. Pharming Group had a negative net margin of 4.14% and a negative trailing twelve-month return on equity of 6.01%.
Read the conference call transcript
.

Shares of PHAR stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Based on aggregate information from My MarketBeat watchlists, some other companies that Pharming Group investors own include Pharming Group (PHGUF), Meta Platforms (META), NVIDIA (NVDA), Sunworks (SUNW), Applied DNA Sciences (APDN), AstraZeneca (AZN) and Costco Wholesale (COST).

Company Calendar

Last Earnings
5/08/2025
Today
7/03/2025
Next Earnings (Estimated)
7/30/2025
Fiscal Year End
12/31/2025

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Sector
Medical
Industry
MED - BIOMED/GENE
Sub-Industry
Pharmaceutical Products
Current Symbol
NASDAQ:PHAR
Fax
N/A
Employees
280
Year Founded
N/A

Price Target and Rating

Average Stock Price Target
$30.00
High Stock Price Target
$39.00
Low Stock Price Target
$14.00
Potential Upside/Downside
+181.7%
Consensus Rating
Buy
Rating Score (0-4)
3.00
Research Coverage
3 Analysts

Profitability

Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
-$11.84 million
Pretax Margin
-1.14%

Debt

Sales & Book Value

Annual Sales
$297.20 million
Cash Flow
$0.07 per share
Price / Cash Flow
144.48
Book Value
$3.25 per share
Price / Book
3.28

Miscellaneous

Free Float
66,623,000
Market Cap
$724.52 million
Optionable
Not Optionable
Beta
0.02
20 Stocks to Sell Now Cover

Today, we are inviting you to take a free peek at our proprietary, exclusive, and up-to-the-minute list of 20 stocks that Wall Street's top analysts hate.

Many of these appear to have good fundamentals and might seem like okay investments, but something is wrong. Analysts smell something seriously rotten about these companies. These are true "Strong Sell" stocks.

Get This Free Report

This page (NASDAQ:PHAR) was last updated on 7/3/2025 by MarketBeat.com Staff
From Our Partners